Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Topical and Nasal AOD-9604 Topical and nasal forms appear in marketing, but the FDA review found no published human exposure data for transdermal or intranasal AOD-9604
however, this change was nonsignificant compared to the placebo group
Recommended Frequency: Monthly
The standard AOD 9604 dosage is 250500 mcg once daily, administered subcutaneously on an empty stomach every morning, and cycled in 412-week blocks
In adipose tissue, inhibition of NNMT suppresses de novo lipogenesis, normalizes fat content, and improves insulin sensitivity 2-3
5-Amino-1MQ 50mg per capsule Ideal For Patients seeking metabolic support, enhanced cellular energy production, and optimized NAD+ metabolism through convenient oral administration
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
